The University of Chicago Header Logo

Connection

David Rubin to Injections, Subcutaneous

Back to Details
This is a "connection" page, showing publications David Rubin has written about Injections, Subcutaneous.
David Rubin
Connection Strength
0.057
Injections, Subcutaneous
  1. Efficacy and safety of intravenous induction and subcutaneous maintenance therapy with guselkumab for patients with Crohn's disease (GALAXI-2 and GALAXI-3): 48-week results from two phase 3, randomised, placebo and active comparator-controlled, double-blind, triple-dummy trials. Lancet. 2025 Jul 26; 406(10501):358-375.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.